# A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis

> **NCT02809781** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 250 (estimated)

## Conditions studied

- Spondylitis
- Spondylitis, Ankylosing
- Ankylosis
- Arthritis
- Spondylarthritis
- Spondylarthropathies
- Spinal Diseases
- Musculoskeletal Diseases
- Bone Diseases

## Interventions

- **BIOLOGICAL:** Intravenous infusion of MSCs
- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT02809781
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2018-08
- **Final completion:** 2018-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2016-06-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02809781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02809781, "A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02809781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*